Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA...

15
Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005

Transcript of Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA...

Page 1: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

Health Care Trends

Biotechnology Council Meeting

Michael J. Rozen M.D.Chair, MTPCIEEE-USA

Washington, D.C.19 March 2005

Page 2: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

I. U.S. Healthcare Expenditure

1.8 Trillion (Traditional) 14.6% GNP

What Do we Get? Life span:

Uninsured Americans: 45 M

Population 295,650,000 (net gain 1 person -12 sec)Uninsured add 1 person every 32 secs.

Page 3: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

http://www.oecd.org/dataoecd/7/58/31785551.pdf

Page 4: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.
Page 5: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.
Page 6: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.
Page 7: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

http://www.post-gazette.com/pg/05055/462144.stm

18.7 %14.6%_______

_______

Page 8: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

Country MS %GNP MD/1000 Res. F LE M LE

USA 14.6 2.4 79.8 74.7Australia 9.1 2.5 82.6 77.4Austria 7.7 3.3 81.1 75.1Canada 9.6 2.1 82.2 77.1Czech Rep. 7.4 3.4 78.7 72.1France 9.7 3.3 82.9 75.6Germany 10.9 3.3 81.3 75.6Ireland 7.3 2.4 80.3 75.2Italy 8.5 4.3 82.9 76.8Japan 7.8 1.9 85.2 78.3Norway 8.7 3.4 81.5 76.4Spain 7.6 2.9 83.1 75.7Sweden 9.2 3.0 82.1 77.7UK 7.7 2.1 80.4 75.7

How Long We Live, How Long They Live

Page 9: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

Fifteen illnesses account for 56% of $200B increase inhealth spending 1987-2000

Page 10: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

II. MTPC-IEEE-USA

Voluntary Universal H/C Identifiers – http://www.ieeeusa.org/policy/positions/healthc

areidentifier.html

Geriatric Symposium– http://www.ieeeusa.org/calendar/conferences/ge

riatrictech/index.html

Tissue Engineering/Stem CellEMR and Interoperability

Page 11: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

VOLUNTARY HEALTHCARE IDENTIFIERApproved by the IEEE-USABoard of Directors, 17 June 2004

IEEE-USA believes the use of voluntary healthcare identifiers can significantly enhance healthcare efficiency and patient safety. Consistent with the framework of the HIPAA legislation, IEEE-USA recommends that legislators and regulators develop and implement policies to create a Voluntary Healthcare Identifier Program and establish demonstration projects to document these benefits.

Policies needed to facilitate adoption include:

Congressional authority and resources for the Department of Health and Human Services and the National Committee on Health and Vital Statistics to develop and

maintain a Voluntary Healthcare Identifier System 

Strong penalties, including monetary, civil and criminal for privacy and security abuses 

Safeguards against current or future unintended use of the information, and 

Incentives for healthcare stakeholders to encourage adoption of Voluntary Healthcare Identifiers

This statement was developed by IEEE-USA's Medical Technology Policy Committee and represents the considered judgment of a group of U.S. IEEE members with expertise in the subject field. IEEE-USA is an organizational unit of the IEEE. It was created in 1973 to advance the public good and promote the careers and public-policy interests of the more than 225,000 technology professionals who are U.S. members of the IEEE. The IEEE is the world's largest technical professional society. For more information, go to http://www.ieeeusa.org.

Page 12: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

Addressing the Healthcare Needs ofOur Aging Population With Technology

4 June 2004

 This report summarizes the findings and recommendations provided by a leading group of geriatric care and scientific scholars at a one-day symposium on June 4, 2004. The symposium goal was to address the healthcare needs of our aging population and to review current technology and recent advancements in geriatric care.

The general recommendations of the symposium are to:

Provide new incentives to encourage physicians to specialize in geriatric care, including financial incentives, regulatory changes and access to technology-based efficiencies

Incorporate information technologies with enhanced communication capabilities into patient care management

Utilize remote sensing to promote efficient and effective patient management between office visits and encourage adoption of home self-care management programs

Make payment methodologies and staff training more effective and more focused on geriatric healthcare needs through the incorporation of innovative technological enhancements

The symposium also developed specific recommendations from the perspectives of the geriatric population, caregivers, medical professionals, and other medical support areas including medical facility and insurance providers and IT system and device makers. Included under these areas are recommendations to: …

Page 13: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

III. OECD Biotechnology

Primary Focus-Agriculture

– Upgraded to full division of OECD

– Projects on Prevention of Biotech research abuse

– Creating Int. inventory of biotech tools

– Developing best practices and guideline re genetics research

– Prioritizing biotech innovation activities

– Collection biostatistics from members

http://www.oecd.org/dataoecd/54/45/34512603.pdf

Page 14: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

IV. Opportunities for Us

Collaboration & Synergistic Alliances

Voluntary Universal Healthcare Identifier National Health Information Infrastructure Adoption of Electronic Medical Records Geriatric Healthcare Medical Device Identification and Tracking

Page 15: Health Care Trends Biotechnology Council Meeting Michael J. Rozen M.D. Chair, MTPC IEEE-USA Washington, D.C. 19 March 2005.

Thank You

Michael J. Rozen M.D.Chair, MTPCIEEE-USA